Table 1.
Isosorbide dinitrate (15) |
|
---|---|
Male sex | 12 (80) |
Age, years | 66±14 |
Height, cm | 170±7 |
BMI kg/m2 | 28.5±3.2 |
Previous PCI | 9 (60) |
Previous MI | 5 (33.3) |
LVEF, % | 57 (51 to 63) |
Diabetes mellitus | 5 (33.3) |
Hypertension | 10 (66.7) |
Hypercholesterolemia | 13 (86.7) |
Family history | 7 (46.7) |
Smoking history | 11 (73.3) |
Current medications | |
Βeta-blocker | 10 (66.7) |
Long-acting nitrate | 6 (40) |
Statin | 12 (80) |
ACEi/AIIRB | 10 (66.7) |
Ca channel antagonist | 4 (26.7) |
Nicorandil | 1 (6.7) |
Aspirin | 14 (93.3) |
Clopidogrel | 14 (93.3) |
Procedural details | |
Diseased vessels | 1 (1 to 2) |
LAD/Cx/RCA | 13/1/2 |
Duration mins | 76 (64 to 91) |
Normally distributed continuous data are displayed as mean ± SD, continuous data that are not normally distributed are presented as median (IQR), and categorical data are presented as n (%), where n is the number of patients in that study group with a certain characteristic. * Indicates P value<0.05. BMI body mass index, PCI percutaneous coronary intervention, MI myocardial infarction, LVEF left ventricular ejection fraction, ACEi angiotensin converting enzyme inhibitor, AIIRB angiotensin II receptor blocker, Pd/Pa mean distal coronary pressure/man aortic pressure, LAD left anterior descending artery, Cx circumflex artery, RCA right coronary artery